User login
Federal Health Care Data Trends 2019
Click here to access Federal Health Care Data Trends 2019
Table of Contents
- American Indian/Alaska Native
- Women's Health
- Department of Veterans Affairs
- Neurologic Disorders
- Diabetes Mellitus
- Infectious Disease
- Hematology/Oncology
- Mental Health
- Respiratory Disorders
- Gastrointestinal Disorders
- Department of Defense
- References
Click here to access Federal Health Care Data Trends 2019
Table of Contents
- American Indian/Alaska Native
- Women's Health
- Department of Veterans Affairs
- Neurologic Disorders
- Diabetes Mellitus
- Infectious Disease
- Hematology/Oncology
- Mental Health
- Respiratory Disorders
- Gastrointestinal Disorders
- Department of Defense
- References
Click here to access Federal Health Care Data Trends 2019
Table of Contents
- American Indian/Alaska Native
- Women's Health
- Department of Veterans Affairs
- Neurologic Disorders
- Diabetes Mellitus
- Infectious Disease
- Hematology/Oncology
- Mental Health
- Respiratory Disorders
- Gastrointestinal Disorders
- Department of Defense
- References
Highlights of the 2019 Update to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report and Their Application in Practice
Click here to read the supplement
Key Points
- The Global Initiative for Chronic Obstructive Lung Disease (GOLD) program releases consensus reports to provide evidence-based recommendations about the management and prevention of chronic obstructive pulmonary disease (COPD);
- The most recent major update occurred in November 2018.
- The 2019 GOLD strategy for COPD assessment now separates lung function measures from respiratory symptom scores because lung function is only weakly correlated to symptoms and health status impairment.
- The updated strategy now provides recommendations for initiation and maintenance of pharmacologic therapy in patients based on exacerbation risk and symptom scores, with consideration of blood eosinophil counts.
- Management of exacerbations now includes the prevention of future exacerbations, which may require adding another medication to the patient's maintenance regimen.
About the Authors:
Jennifer Banfield, APRN, FNP
Clinical Research Coordinator
Boys Town National Research Hospital
Boys Town, Nebraska
Kevin R. Murphy, MD
Director of Allergy, Asthma, and Pulmonary Research
Boys Town National Research Hospital
Boys Town, Nebraska
University of Nebraska Medical Center
Creighton University School of Medicine
Omaha, Nebraska
Click here to read the supplement
Key Points
- The Global Initiative for Chronic Obstructive Lung Disease (GOLD) program releases consensus reports to provide evidence-based recommendations about the management and prevention of chronic obstructive pulmonary disease (COPD);
- The most recent major update occurred in November 2018.
- The 2019 GOLD strategy for COPD assessment now separates lung function measures from respiratory symptom scores because lung function is only weakly correlated to symptoms and health status impairment.
- The updated strategy now provides recommendations for initiation and maintenance of pharmacologic therapy in patients based on exacerbation risk and symptom scores, with consideration of blood eosinophil counts.
- Management of exacerbations now includes the prevention of future exacerbations, which may require adding another medication to the patient's maintenance regimen.
About the Authors:
Jennifer Banfield, APRN, FNP
Clinical Research Coordinator
Boys Town National Research Hospital
Boys Town, Nebraska
Kevin R. Murphy, MD
Director of Allergy, Asthma, and Pulmonary Research
Boys Town National Research Hospital
Boys Town, Nebraska
University of Nebraska Medical Center
Creighton University School of Medicine
Omaha, Nebraska
Click here to read the supplement
Key Points
- The Global Initiative for Chronic Obstructive Lung Disease (GOLD) program releases consensus reports to provide evidence-based recommendations about the management and prevention of chronic obstructive pulmonary disease (COPD);
- The most recent major update occurred in November 2018.
- The 2019 GOLD strategy for COPD assessment now separates lung function measures from respiratory symptom scores because lung function is only weakly correlated to symptoms and health status impairment.
- The updated strategy now provides recommendations for initiation and maintenance of pharmacologic therapy in patients based on exacerbation risk and symptom scores, with consideration of blood eosinophil counts.
- Management of exacerbations now includes the prevention of future exacerbations, which may require adding another medication to the patient's maintenance regimen.
About the Authors:
Jennifer Banfield, APRN, FNP
Clinical Research Coordinator
Boys Town National Research Hospital
Boys Town, Nebraska
Kevin R. Murphy, MD
Director of Allergy, Asthma, and Pulmonary Research
Boys Town National Research Hospital
Boys Town, Nebraska
University of Nebraska Medical Center
Creighton University School of Medicine
Omaha, Nebraska
Practical advice for colorectal cancer screening
Douglas K. Rex, MD, AGAF, MACP, MACG, FASGE; offers advice and insight for colorectal cancer screening, highlighting:
- Clinically relevant facts about the spectrum of precancerous lesions that can be targeted during screening;
- Key practical aspects of the 3 screening tests that receive significant use in the United States.
- Why some tests are used more than others
Click HERE to read the supplement
Douglas K. Rex, MD, AGAF, MACP, MACG, FASGE; offers advice and insight for colorectal cancer screening, highlighting:
- Clinically relevant facts about the spectrum of precancerous lesions that can be targeted during screening;
- Key practical aspects of the 3 screening tests that receive significant use in the United States.
- Why some tests are used more than others
Click HERE to read the supplement
Douglas K. Rex, MD, AGAF, MACP, MACG, FASGE; offers advice and insight for colorectal cancer screening, highlighting:
- Clinically relevant facts about the spectrum of precancerous lesions that can be targeted during screening;
- Key practical aspects of the 3 screening tests that receive significant use in the United States.
- Why some tests are used more than others
Click HERE to read the supplement
Impetigo: Addressing Treatment Challenges and Burden of Disease
Over the past few decades there has been a shift in the bacteriology and resistance patterns associated with impetigo, making it difficult to identify the best treatment choice for this common bacterial skin infection. In this supplement to Dermatology News, Adelaide A. Hebert, MD and Linda F. Stein Gold, MD, review the current impetigo treatment landscape and the growing concern over methicillin-resistant S. aureus (MRSA).
Over the past few decades there has been a shift in the bacteriology and resistance patterns associated with impetigo, making it difficult to identify the best treatment choice for this common bacterial skin infection. In this supplement to Dermatology News, Adelaide A. Hebert, MD and Linda F. Stein Gold, MD, review the current impetigo treatment landscape and the growing concern over methicillin-resistant S. aureus (MRSA).
Over the past few decades there has been a shift in the bacteriology and resistance patterns associated with impetigo, making it difficult to identify the best treatment choice for this common bacterial skin infection. In this supplement to Dermatology News, Adelaide A. Hebert, MD and Linda F. Stein Gold, MD, review the current impetigo treatment landscape and the growing concern over methicillin-resistant S. aureus (MRSA).
Practical advice for colorectal cancer screening
Douglas K. Rex, MD, AGAF, MACP, MACG, FASGE; offers advice and insight for colorectal cancer screening, highlighting:
- Clinically relevant facts about the spectrum of precancerous lesions that can be targeted during screening;
- Key practical aspects of the 3 screening tests that receive significant use in the United States.
- Why some tests are used more than others
Click HERE to read the supplement
Douglas K. Rex, MD, AGAF, MACP, MACG, FASGE; offers advice and insight for colorectal cancer screening, highlighting:
- Clinically relevant facts about the spectrum of precancerous lesions that can be targeted during screening;
- Key practical aspects of the 3 screening tests that receive significant use in the United States.
- Why some tests are used more than others
Click HERE to read the supplement
Douglas K. Rex, MD, AGAF, MACP, MACG, FASGE; offers advice and insight for colorectal cancer screening, highlighting:
- Clinically relevant facts about the spectrum of precancerous lesions that can be targeted during screening;
- Key practical aspects of the 3 screening tests that receive significant use in the United States.
- Why some tests are used more than others
Click HERE to read the supplement
Meeting Highlights: Cardiovascular Research Technologies 2019
A supplement to Cardiology News. This supplement was sponsored by Chiesi USA, Inc.
News included in the supplement:
- Ultrathin stent loses advantage at 3 years
- Adjunctive devices for TAVR boost outcomes
- MI alert device shows predictive value
- Readmissions high post STEMI with cardiogenic shock
- Endovascular device sustains BP reductions
- Alcohol renal denervation safe for BP reduction
A supplement to Cardiology News. This supplement was sponsored by Chiesi USA, Inc.
News included in the supplement:
- Ultrathin stent loses advantage at 3 years
- Adjunctive devices for TAVR boost outcomes
- MI alert device shows predictive value
- Readmissions high post STEMI with cardiogenic shock
- Endovascular device sustains BP reductions
- Alcohol renal denervation safe for BP reduction
A supplement to Cardiology News. This supplement was sponsored by Chiesi USA, Inc.
News included in the supplement:
- Ultrathin stent loses advantage at 3 years
- Adjunctive devices for TAVR boost outcomes
- MI alert device shows predictive value
- Readmissions high post STEMI with cardiogenic shock
- Endovascular device sustains BP reductions
- Alcohol renal denervation safe for BP reduction
NHIA Conference Wrap-Up
This supplement to Neurology Reviews compiles news briefs from the 2019 National Home Infusion Association annual meeting, which was held in March in Orlando, Florida.
Click here to read the supplement.
This supplement to Neurology Reviews compiles news briefs from the 2019 National Home Infusion Association annual meeting, which was held in March in Orlando, Florida.
Click here to read the supplement.
This supplement to Neurology Reviews compiles news briefs from the 2019 National Home Infusion Association annual meeting, which was held in March in Orlando, Florida.
Click here to read the supplement.